AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19840500 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate post space preparation using LA Axxess burs
Number of subjects: 66
Study 19840500 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed post space preparation using LA Axxess burs
Number of subjects: 66
Study 19840500 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate post space preparation using heated pluggers
Number of subjects: 66
Study 19840500 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed post space preparation using heated pluggers
Number of subjects: 66
Study 19840500 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate post space preparation using solvent delivered with a hand file
Number of subjects: 66
Study 19840500 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed post space preparation using solvent delivered with a hand file
Number of subjects: 66
Study 19840500 — intervention group
Group type: COMPARATOR
Intervention: Positive control (instrumented but not obturated)
Number of subjects: 66
Study 19840500 — intervention group
Group type: COMPARATOR
Intervention: Negative control (instrumented, obturated and sealed with Cavit)
Number of subjects: 66
Study 16387410 — intervention group
Group type: EXPERIMENTAL
Intervention: Lich-Gregoir reimplantation
Number of subjects: 44
Study 16387410 — intervention group
Group type: COMPARATOR
Intervention: Politano-Leadbetter technique
Number of subjects: 44
Study 14762667 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.8 Hz vibration (group A)
Number of subjects: 60
Study 14762667 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 Hz vibration (group B)
Number of subjects: 60
Study 14762667 — intervention group
Group type: COMPARATOR
Intervention: No vibration (group C)
Number of subjects: 60
Study 11028730 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine
Number of subjects: 30
Study 11028730 — intervention group
Group type: COMPARATOR
Intervention: 0.2% bupivacaine
Number of subjects: 30
Study 9305328 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous levodopa (LD) administered over a wide dose range
Number of subjects: 25
Study 9305328 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levodopa doses
Number of subjects: 25
Study 9305328 — intervention group
Group type: EXPERIMENTAL
Intervention: Smaller, more frequent levodopa doses
Number of subjects: 25
Study 8280213 — intervention group
Group type: EXPERIMENTAL
Intervention: Guidelines for general practice management and referral of infertile couples
Number of subjects: 200
Study 3539632 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusions of prostacyclin
Number of subjects: 9
Study 3539632 — intervention group
Group type: COMPARATOR
Intervention: Placebo (solvent) infusions
Number of subjects: 9
Study 30222916 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorcaserin
Number of subjects: 137
Study 30222916 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study 26711715 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal indomethacin
Number of subjects: 82
Study 26711715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 24555909 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic device (UC)
Number of subjects: 43
Study 24555909 — intervention group
Group type: COMPARATOR
Intervention: Standard electric dissection (ELC)
Number of subjects: 43
Study 22694484 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan iontophoretic transdermal system
Number of subjects: 469
Study 22694484 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 469
Study 19910265 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 1mg/kg
Number of subjects: 16
Study 19910265 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide 60%
Number of subjects: 16
Study 19910265 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 16
Study 19910265 — intervention group
Group type: COMPARATOR
Intervention: Nitrogen (Control)
Number of subjects: 16
Study 18506661 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography (CT) screening for lung cancer
Number of subjects: 0
Study 18506661 — intervention group
Group type: COMPARATOR
Intervention: Usual clinical practice
Number of subjects: 0
Study 15925046 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 67
Study 15925046 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone
Number of subjects: 67
Study 12720115 — intervention group
Group type: EXPERIMENTAL
Intervention: EMD plus selective COX-2 inhibitor (rofecoxib 12.5 mg twice daily for 14 days)
Number of subjects: 22
Study 12720115 — intervention group
Group type: COMPARATOR
Intervention: EMD alone
Number of subjects: 22
Study 11093293 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat high simple carbohydrate group
Number of subjects: 398
Study 11093293 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat high complex carbohydrate group
Number of subjects: 398
Study 11093293 — intervention group
Group type: COMPARATOR
Intervention: Control diet group
Number of subjects: 398
Study 11093293 — intervention group
Group type: COMPARATOR
Intervention: Seasonal control group
Number of subjects: 398
Study 8857675 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrafiltration
Number of subjects: 18
Study 8857675 — intervention group
Group type: COMPARATOR
Intervention: Control (no ultrafiltration)
Number of subjects: 18
Study 1514343 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 10 micrograms.kg‐1
Number of subjects: 100
Study 1514343 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 15 micrograms.kg‐1
Number of subjects: 100
Study 1514343 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 20 micrograms.kg‐1
Number of subjects: 100
Study 1514343 — intervention group
Group type: COMPARATOR
Intervention: Lignocaine 10 mg mixed with propofol
Number of subjects: 100
Study 1514343 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil
Number of subjects: 100
Study 1514343 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil and propofol
Number of subjects: 100
Study 6395527 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 dragées (drg.) Actovegin
Number of subjects: 10
Study 6395527 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 dragées (drg.) Actovegin
Number of subjects: 10
Study 6395527 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 30607535 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotigotine (PD-Rot)
Number of subjects: 42
Study 30607535 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PD-Pla)
Number of subjects: 42
Study 28056410 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 minutes of intense exercise
Number of subjects: 62
Study 28056410 — intervention group
Group type: COMPARATOR
Intervention: Slow walking (control condition)
Number of subjects: 62
Study 27298402 — intervention group
Group type: EXPERIMENTAL
Intervention: Histologic transformation (HT)
Number of subjects: 1018
Study 27298402 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage treatment for HT
Number of subjects: 1018
Study 27298402 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival for patients with HT
Number of subjects: 1018
Study 27298402 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation for HT
Number of subjects: 1018
Study 26287058 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational materials regarding living kidney donation (n = 78)
Number of subjects: 149
Study 26287058 — intervention group
Group type: COMPARATOR
Intervention: No educational materials regarding living kidney donation (n = 71)
Number of subjects: 149
Study 26287058 — intervention group
Group type: EXPERIMENTAL
Intervention: Acquaintance with a transplant recipient
Number of subjects: 149
Study 21807984 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Early and Frequent Mobilization (VEM)
Number of subjects: 71
Study 21807984 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 71
Study 19127436 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir-loaded microparticles (15% drug load)
Number of subjects: 10
Study 19127436 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir-loaded microparticles (90% drug load)
Number of subjects: 10
Study 19127436 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir-loaded microparticles
Number of subjects: 10
Study 17609916 — intervention group
Group type: EXPERIMENTAL
Intervention: Glossy Ganoderma Decoction (GGD) combined with conventional treatment (penicillin and reduced glutathione)
Number of subjects: 23
Study 17609916 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (penicillin and reduced glutathione) alone
Number of subjects: 23
Study 15055896 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 40
Study 15055896 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 40
Study 11829202 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (150 mg weekly)
Number of subjects: 132
Study 11829202 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study 9625398 — intervention group
Group type: EXPERIMENTAL
Intervention: Garlic powder (900 mg/d)
Number of subjects: 50
Study 9625398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 7836218 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffer treatment (alkali loading) during constant-intensity exercise at 85% of maximal exertion
Number of subjects: 7
Study 7836218 — intervention group
Group type: COMPARATOR
Intervention: Placebo during constant-intensity exercise at 85% of maximal exertion
Number of subjects: 7
Study 3254768 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 35
Study 3254768 — intervention group
Group type: EXPERIMENTAL
Intervention: Bendroflumethiazide
Number of subjects: 35
Study 3254768 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 35
Study 31539358 — intervention group
Group type: EXPERIMENTAL
Intervention: Life skills training with health literacy strategies
Number of subjects: 96
Study 31539358 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 96
Study 28698991 — intervention group
Group type: EXPERIMENTAL
Intervention: Thulium vapoenucleation of the prostate (ThuVEP)
Number of subjects: 94
Study 28698991 — intervention group
Group type: COMPARATOR
Intervention: Holmium laser enucleation of the prostate (HoLEP)
Number of subjects: 94
Study 25627640 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 15
Study 25627640 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-Body Vibration Training associated with Resistance Training (WBV + RT)
Number of subjects: 15
Study 24028076 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganirelix started on day 5 of ovarian stimulation
Number of subjects: 2096
Study 24028076 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganirelix started on day 6 of ovarian stimulation
Number of subjects: 2096
Study 24028076 — intervention group
Group type: COMPARATOR
Intervention: No LH rise prior to ganirelix treatment
Number of subjects: 2096
Study 24028076 — intervention group
Group type: COMPARATOR
Intervention: No LH rise during ganirelix treatment
Number of subjects: 2096
Study 24028076 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with LH rise during ganirelix treatment
Number of subjects: 2096
Study 21255534 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg and ASA 325 mg in a single capsule
Number of subjects: 49
Study 21255534 — intervention group
Group type: COMPARATOR
Intervention: Separate monotherapies of esomeprazole 40 mg and ASA 325 mg
Number of subjects: 49
Study 19485593 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal intervention (student curriculum and teacher training)
Number of subjects: 5581
Study 19485593 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective intervention (family intervention for high aggression students)
Number of subjects: 5581
Study 19485593 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention
Number of subjects: 5581
Study 19485593 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 5581
Study 16481959 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Cobb angle
Number of subjects: 120
Study 16481959 — intervention group
Group type: EXPERIMENTAL
Intervention: Digitized Cobb angle
Number of subjects: 120
Study 16481959 — intervention group
Group type: COMPARATOR
Intervention: Debrunner kyphometer
Number of subjects: 120
Study 16351536 — intervention group
Group type: EXPERIMENTAL
Intervention: Queensland Case Conferences trial (QCC)
Number of subjects: 0
Study 16351536 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative Care Trial (PCT)
Number of subjects: 0
Study 16351536 — intervention group
Group type: COMPARATOR
Intervention: PCT
Number of subjects: 0
Study 16351536 — intervention group
Group type: COMPARATOR
Intervention: QCC
Number of subjects: 0
Study 16351536 — intervention group
Group type: COMPARATOR
Intervention: Both studies
Number of subjects: 0
Study 12490865 — intervention group
Group type: EXPERIMENTAL
Intervention: Parathyroidectomy (group A)
Number of subjects: 50
Study 12490865 — intervention group
Group type: COMPARATOR
Intervention: Observation (group B)
Number of subjects: 50
Study 9534693 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D T2* MRI
Number of subjects: 20
Study 9534693 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadolinium enhanced 2D T1 MRI
Number of subjects: 20
Study 9534693 — intervention group
Group type: COMPARATOR
Intervention: CT myelography
Number of subjects: 20
Study 7630673 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.6 mg/kg)
Number of subjects: 38
Study 7630673 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 38
Study 2651244 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-interferon gel (100,000 IU/g), self-administered 4 times daily to the affected areas.
Number of subjects: 28
Study 2651244 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in half the patients, double-blind, cross-over study).
Number of subjects: 28
Study 174489 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenine arabinoside ointment
Number of subjects: 32
Study 174489 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 31825248 — intervention group
Group type: EXPERIMENTAL
Intervention: SAR341402 insulin aspart
Number of subjects: 30
Study 31825248 — intervention group
Group type: EXPERIMENTAL
Intervention: NovoLog® (US-sourced insulin aspart)
Number of subjects: 30
Study 31825248 — intervention group
Group type: EXPERIMENTAL
Intervention: NovoRapid® (EU-sourced insulin aspart)
Number of subjects: 30
Study 30784040 — intervention group
Group type: EXPERIMENTAL
Intervention: Headache-Specific Locus of Control scale
Number of subjects: 695
Study 28673747 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine screening intervention in primary care offices and Federally Qualified Health Centers
Number of subjects: 906
Study 25539467 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid withdrawal (CW)
Number of subjects: 196
Study 25539467 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid continuation (CC)
Number of subjects: 196
Study 21775111 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment (Losartan)
Number of subjects: 875
Study 21669959 — intervention group
Group type: EXPERIMENTAL
Intervention: Household smoking ban
Number of subjects: 99
Study 19635145 — intervention group
Group type: EXPERIMENTAL
Intervention: Powdered supplement (30 mg iron as micronized dispersible ferric pyrophosphate, 600 mug folic acid)
Number of subjects: 18
Study 19635145 — intervention group
Group type: COMPARATOR
Intervention: Tablet supplement (27 mg iron from ferrous fumarate, 1000 mug folic acid)
Number of subjects: 18
Study 16749412 — intervention group
Group type: EXPERIMENTAL
Intervention: Lornoxicam (8 mg)
Number of subjects: 60
Study 16749412 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen (100 mg)
Number of subjects: 60
Study 16749412 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 60
Study 15243305 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NMMA (0.8 mg/min/dL)
Number of subjects: 17
Study 15243305 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NMMA (1.6 mg/min/dL)
Number of subjects: 17
Study 15243305 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NMMA (EC50)
Number of subjects: 17
Study 15243305 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NMMA (Maximal vasoconstrictive response)
Number of subjects: 17
Study 15243305 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure
Number of subjects: 17
Study 11336846 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound screening for AAA
Number of subjects: 12203
Study 9271777 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH (50 micrograms hourly between 22.00 h and 1.00 h, 4 x 50 micrograms)
Number of subjects: 2
Study 9271777 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH (after priming)
Number of subjects: 2
Study 9271777 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study 8188163 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha 2a high dose (18 MU/day)
Number of subjects: 0
Study 8188163 — intervention group
Group type: COMPARATOR
Intervention: Interferon-alpha 2a low dose (3 MU/day)
Number of subjects: 0
Study 2897008 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 23
Study 2897008 — intervention group
Group type: COMPARATOR
Intervention: Penicillin
Number of subjects: 23
Study 2897008 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone 4 g/day
Number of subjects: 23
Study 2897008 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone 2 g/day
Number of subjects: 23
Study 29520533 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (AC) - twice weekly manual acupuncture over six weeks
Number of subjects: 82
Study 29520533 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (AC)
Number of subjects: 82
Study 29520533 — intervention group
Group type: COMPARATOR
Intervention: Usual care wait-list control (WL)
Number of subjects: 82
Study 27943570 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-Delivered Cognitive Behavioural Therapy (T-CBT)
Number of subjects: 118
Study 27943570 — intervention group
Group type: COMPARATOR
Intervention: CBT face to face treatment as usual (TAU-CBT)
Number of subjects: 118
Study 27943570 — intervention group
Group type: EXPERIMENTAL
Intervention: Both T-CBT and TAU-CBT
Number of subjects: 118
Study 27943570 — intervention group
Group type: COMPARATOR
Intervention: TAU-CBT
Number of subjects: 118
Study 27943570 — intervention group
Group type: EXPERIMENTAL
Intervention: T-CBT
Number of subjects: 118
Study 26181225 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) over the auditory cortex
Number of subjects: 19
Study 26181225 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal hearing)
Number of subjects: 19
Study 22791597 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal sonography (TVS)
Number of subjects: 50639
Study 21672205 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (CBT) - 5 to 10 sessions based on the Salkovskis/Warwick model.
Number of subjects: 466
Study 21672205 — intervention group
Group type: COMPARATOR
Intervention: Control group - standard care including clinical assessment, appropriate tests, and reassurance.
Number of subjects: 466
Study 18490527 — intervention group
Group type: EXPERIMENTAL
Intervention: Abciximab (glycoprotein IIb/IIIa inhibitor)
Number of subjects: 100
Study 18490527 — intervention group
Group type: COMPARATOR
Intervention: Stenting alone
Number of subjects: 100
Study 18490527 — intervention group
Group type: COMPARATOR
Intervention: Stenting with embolic protection (Angioguard)
Number of subjects: 100
Study 18490527 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (Stenting with both embolic protection and abciximab)
Number of subjects: 100
Study 18490527 — intervention group
Group type: COMPARATOR
Intervention: Embolic protection (Angioguard)
Number of subjects: 100
Study 16448810 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP with distal oxygen connection point
Number of subjects: 10
Study 16448810 — intervention group
Group type: EXPERIMENTAL
Intervention: NIPPV
Number of subjects: 10
Study 16448810 — intervention group
Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 10
Study 12973486 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg lamivudine daily for 6 months
Number of subjects: 62
Study 12973486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 11019866 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol-assisted mechanical debridement
Number of subjects: 9
Study 11019866 — intervention group
Group type: COMPARATOR
Intervention: Transepithelial phototherapeutic keratectomy (PTK)
Number of subjects: 9
Study 8712035 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of Results (KR) group practiced 200 trials a day for 5 days, then 1 day without KR.
Number of subjects: 200
Study 8712035 — intervention group
Group type: COMPARATOR
Intervention: No Knowledge of Results (no-KR) group practiced 200 trials for one day.
Number of subjects: 200
Study 1330079 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamimmune N
Number of subjects: 42
Study 1330079 — intervention group
Group type: EXPERIMENTAL
Intervention: Immune Globulin Intravenous
Number of subjects: 42
Study 1330079 — intervention group
Group type: EXPERIMENTAL
Intervention: Gammagard
Number of subjects: 42
Study 1330079 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandoglobulin
Number of subjects: 42
Study 3882615 — intervention group
Group type: EXPERIMENTAL
Intervention: iohexol
Number of subjects: 363
Study 3882615 — intervention group
Group type: COMPARATOR
Intervention: iopamidol
Number of subjects: 363
Study 3882615 — intervention group
Group type: EXPERIMENTAL
Intervention: Both iohexol and iopamidol
Number of subjects: 363
Study 30821515 — intervention group
Group type: EXPERIMENTAL
Intervention: FES-Cycling
Number of subjects: 8
Study 30821515 — intervention group
Group type: COMPARATOR
Intervention: Placebo-FES
Number of subjects: 8
Study 29252011 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET) plus Family Check-Up (FCU)
Number of subjects: 69